Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults

Journal of Neuroscience

Volumn 35, Issue 4, 2015, Pages 1505-1512

  Weiland, Xbarbara J ^a   Thayer, Rachel E ^a   Depue, Xbrendan E ^b   Sabbineni, Amithrupa ^a   Bryan, Angela D ^a   Hutchison, Kent E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Gray matter; Marijuana; Morphology; MRI

Indexed keywords

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; AMYGDALOID NUCLEUS; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BRAIN MORPHOLOGY; CANNABIS USE; CEREBELLUM; DRUG EFFECT; FEMALE; GENDER; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; MORPHOLOGY; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SHAPE ANALYSIS; SMOKING; STATISTICAL ANALYSIS; SURFACE BASED MORPHOMETRY; TIME LINE FOLLOW BACK; VOXEL BASED MORPHOMETRY; ZUCKERMAN KUHLMAN PERSONALITY QUESTIONNAIRE; AGING; BRAIN; CANNABIS SMOKING; DOSE RESPONSE; IMAGE PROCESSING; NONPARAMETRIC TEST; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA SMOKING; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84921928755     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2946-14.2015     Document Type: Article

References (66)

1. Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL (2007) Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther 82:572–578. CrossRef Medline
2. Ashburner J, Friston KJ (2000) Voxel-based morphometry—the methods. Neuroimage 11:805– 821. CrossRef Medline
3. Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, Cook P, Gee J, Sevy S, Kumra S (2011) Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res 45:1055– 1066. CrossRef Medline
4. Battistella G, Fornari E, Annoni JM, Chtioui H, Dao K, Fabritius M, Favrat B, Mall JF, Maeder P, Giroud C (2014) Long-term effects of cannabis on brain structure. Neuropsychopharmacology 39:2041–2048. CrossRef Medline
5. Beck AT, Ward CH, Mendelson MM, Mock JJ, Erbaugh JJ (1961) An inventory for measuring depression. Arch Gen Psych 4:561–571. CrossRef
6. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893– 897. CrossRef Medline
7. Block RI, O’Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, Arndt S, Hall JA (2000) Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 11:491– 496. CrossRef Medline
8. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, CraigIW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117–1127. CrossRef Medline
9. Claus ED, Ewing SW, Filbey FM, Sabbineni A, Hutchison KE (2011) Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology 36:2086 –2096. CrossRef Medline
10. Cohen J (1988) Statistical power analysis for the behavioral sciences, Ed 2. Hillsdale, NJ: Earlbaum. Cohen J (1994) The earth is round (p _ 0.05). Am Psychologist 49:997– 1003. CrossRef
11. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE (2012) Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 59:3845–3851. CrossRef Medline
12. Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R (2013) Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 23:117–137. CrossRef Medline
13. Cumming G (2012) Understanding the new statistics: effect sizes, confidence intervals, and meta-analysis. New York: Routledge. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis: I. Segmentation and surface reconstruction. Neuroimage 9:179 –194. CrossRef Medline
14. Decoster J, van Os J, Myin-Germeys I, De Hert M, van Winkel R (2012) Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions. Curr Pharm Des 18:5015–5023. CrossRef Medline
15. Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Mann K, HermannD (2011) Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 114:242–245. CrossRef Medline
16. Depue BE, Banich MT (2012) Increased inhibition and enhancement of memory retrieval are associated with reduced hippocampal volume. Hippocampus 22:651– 655. CrossRef Medline
17. Depue BE, Olson-Madden JH, Smolker HR, Rajamani M, Brenner LA, Banich MT (2014) Reduced amygdala volume is associated with deficits in inhibitory control: a voxel- and surface-based morphometric analysis of comorbid PTSD/mild TBI. Biomed Res Int 2014:691505. CrossRef Medline
18. Durazzo TC, Tosun D, Buckley S, Gazdzinski S, Mon A, Fryer SL, Meyerhoff DJ (2011) Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence. Alcohol Clin Exp Res 35:1187–1200. CrossRef Medline
19. Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ (2002) Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol Clin Exp Res 26:558 –564. CrossRef Medline
20. Fein G, Landman B, Tran H, McGillivray S, Finn P, Barakos J, Moon K (2006) Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task. Neuroimage 32:1465–1471. CrossRef Medline
21. Filbey FM, Aslan S, Calhoun VD, Spence JS, Damaraju E, Caprihan A, Segall J (2014) Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A 111:16913–16918. CrossRef Medline
22. Fischl B, Salat DH, van der Kouwe AJW, Makris N, Se´gonne F, Quinn BT, Dale AM (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23 [Suppl 1]:69 –84. CrossRef Medline
23. Gao Y, Riklin-Raviv T, Bouix S (2014) Shape analysis, a field in need of careful validation. Hum Brain Mapp 35:4965– 4978. CrossRef Medline
24. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15:870–878. CrossRef Medline
25. Gilman JM, Kuster JK, Lee S, Lee MJ, Kim BW, Makris N, van der Kouwe A, Blood AJ, Breiter HC (2014) Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci 34:5529 –5538. CrossRef Medline
26. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36. CrossRef Medline
27. Harper C (2009) The neuropathology of alcohol-related brain damage. Alcohol Alcoholism 44:136 –140. CrossRef Medline
28. Harper C, Kril J (1985) Brain atrophy in chronic alcoholic patients: a quantitative pathological study. J Neurol Neurosurg Psychiatry 48:211–217. CrossRef Medline
29. Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198 –204. CrossRef Medline
30. Jernigan TL, Butters N, DiTraglia G, Schafer K, Smith T, Irwin M, Grant I, Schuckit M, Cermak LS (1991) Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res 15:418–427. CrossRef Medline
31. Kovacs M (1992) Children’s depression inventory. New York: Multi-Health Systems. Krueger J (2001) Null hypothesis significance testing. On the survival of a flawed method. Am Psychol 56:16 –26. CrossRef Medline
32. Lisdahl KM, Wright NE, Kirchner-Medina C, Maple KE, Shollenbarger S (2014) Considering cannabis: the effects of regular cannabis use on neurocognition in adolescents and young adults. Curr Addict Rep 1:144 –156. CrossRef Medline
33. Lorenzetti V, Solowij N, Fornito A, Lubman DI, Yucel M (2014) The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature. Curr Pharm Des 20:2138 –2167. CrossRef Medline
34. Magnan RE, Callahan TJ, Ladd BO, Claus ED, Hutchison KE, Bryan AD (2013) Evaluating an integrative theoretical framework for HIV sexual risk among juvenile justice involved adolescents. J AIDS Clin Res 4:217. Medline
35. Makris N, Oscar-Berman M, Jaffin SK, Hodge SM, Kennedy DN, Caviness VS, Marinkovic K, Breiter HC, Gasic GP, Harris GJ (2008) Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64:192– 202. CrossRef Medline
36. McClelland GH (1997) Optimal design in psychological research. Psychol Methods 2:3–19. CrossRef
37. McQueeny T, Padula CB, Price J, Medina KL, Logan P, Tapert SF (2011) Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res 224:128 –134. CrossRef Medline
38. Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF (2007a) Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol 29:141–152. CrossRef Medline
39. Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF (2007b) Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatry 48:592– 600. CrossRef Medline
40. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Schweinsburg AD, Tapert SF (2008) Prefrontal cortex volumes in adolescents with alcohol use disorders: unique gender effects. Alcohol Clin Exp Res 32:386 –394. CrossRef Medline
41. Medina KL, Nagel BJ, Tapert SF (2010) Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res 182:152–159. CrossRef Medline
42. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE (2012) Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 109:2657–2664. CrossRef Medline
43. Miller GA, Chapman JP (2001) Misunderstanding analysis of covariance. J Abnorm Psychol 110:40–48. CrossRef Medline
44. Nagel BJ, Schweinsburg AD, Phan V, Tapert SF (2005) Reduced hippocampal volume among adolescents with alcohol use disorders without psychiatric comorbidity. Psychiatry Res 139:181–190. CrossRef Medline
45. Niesink RJ, van Laar MW (2013) Does cannabidiol protect against adverse psychological effects of THC? Front Psychiatry 4:130. CrossRef Medline
46. Office of Juvenile Justice and Delinquency Prevention (2009) The National Juvenile Court Data Archive. Pittsburgh, PA: National Center for Juvenile Justice. E-book available at http://www.ojjdp.gov/pubs/239114.pdf.
47. Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C, Wolf PA (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363–1367. CrossRef Medline
48. Pfefferbaum A, Lim KO, Zipursky RB, Mathalon DH, Rosenbloom MJ, Lane B, Ha CN, Sullivan EV (1992) Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res 16:1078 –1089. CrossRef Medline
49. Ranganathan M, D’Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188:425– 444. CrossRef Medline
50. Rogeberg O (2013) Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proc Natl Acad Sci U S A 110:4251– 4254. CrossRef Medline
51. Russo EB (2007) History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 4:1614 –1648. CrossRef Medline
52. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 88:791– 804. CrossRef Medline
53. Schacht JP, Hutchison KE, Filbey FM (2012) Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology 37:2368– 2376. CrossRef Medline
54. Segobin SH, Chetelat G, Le Berre AP, Lannuzel C, Boudehent C, Vabret F, Eustache F, Beaunieux H, Pitel AL (2014) Relationship between brain volumetric changes and interim drinking at six months in alcoholdependent patients. Alcohol Clin Exp Res 38:739 –748. CrossRef Medline
55. Sobell LC, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Measuring alcohol consumption: psychosocial and biochemical methods (Litten RZ, Allen JP, eds), pp 41–72. Clifton, NJ: Humana.
56. Solowij N, Yucel M, Respondek C, Whittle S, Lindsay E, Pantelis C, Lubman DI (2011) Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol Med 41:2349 –2359. CrossRef Medline
57. Squeglia LM, Sorg SF, Schweinsburg AD, Wetherill RR, Pulido C, Tapert SF (2012) Binge drinking differentially affects adolescent male and female brain morphometry. Psychopharmacology (Berl) 220:529 –539. CrossRef Medline
58. Sullivan EV (2007) Alcohol and drug dependence: brain mechanisms and behavioral impact. Neuropsychol Rev 17:235–238. CrossRef Medline
59. Sullivan EV, Deshmukh A, Desmond JE, Mathalon DH, Rosenbloom MJ, Lim KO, Pfefferbaum A (2000) Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch Gen Psychiatry 57:894– 902. CrossRef Medline
60. Torvik A, Torp S, Lindboe CF (1986) Atrophy of the cerebellar vermis in ageing. A morphometric and histologic study. J Neurol Sci 76:283–294. CrossRef Medline
61. Tzilos GK, Cintron CB, Wood JB, Simpson NS, Young AD, Pope HG Jr, Yurgelun-Todd DA (2005) Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict 14:64 –72. CrossRef Medline
62. Weiland BJ, Korycinski ST, Soules M, Zubieta JK, Zucker RA, Heitzeg MM (2014) Substance abuse risk in emerging adults associated with smaller frontal gray matter volumes and higher externalizing behaviors. Drug Alcohol Depend 137:68 –75. CrossRef Medline
63. White HR, Labouvie EW (1989) Towards the assessment of adolescent problem drinking. J Stud Alcohol Drugs 50:30 –37.
64. Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T, Beckmann C, Jenkinson M, Smith SM (2009) Bayesian analysis of neuroimaging data in FSL. Neuroimage 45:173–186. CrossRef Medline
65. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65:694 –701. CrossRef Medline
66. Zuckerman M, Kuhlman DM, Joireman J, Teta P, Kraft M (1993) A comparison of three structural models for personality: the big three, the big five, and the alternative five. J Pers Soc Psychol 65:757–768. CrossRef